Achieve Life Sciences Inc (ACHV NASDAQ) stock market data APIs
$7.0364
-0.11(-1.6%)
as of November 4, 2026
Try our APIs with
free plan!
Achieve Life Sciences Inc Financial Data Overview
Price chart is built with
Anychart
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Prev. Close
7.0364
Open
6.9277
High
7.0943
Low
6.8468
52 wk Range
2.62-8.64
Market Cap
694 M
Shares Outstanding
103 M
Beta
2.408
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Achieve Life Sciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Achieve Life Sciences Inc data using free add-ons & libraries
Get Achieve Life Sciences Inc Fundamental Data
Achieve Life Sciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -58 053 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Achieve Life Sciences Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-11-05
- EPS/Forecast: -0.2
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Achieve Life Sciences Inc News
New
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
Lisata Therapeutics, Inc. Veteran biopharma CFO brings more than 15 years of public-company financial leadership across development, approval and commercial launch; joins Audit Committee LIBERTY COR...
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit.
Pile of money with hands by Sergey Nazarov via iStock Achieve Life Sciences (ACHV) is a $685 million biotech focused on cytisinicline-based nicotine addiction treatments, showing strong recent techni...
Achieve Life Sciences GAAP EPS of -$0.80 misses by $0.64
* Achieve Life Sciences press release [https://seekingalpha.com/pr/20614674-achieve-life-sciences-reports-second-quarter-2026-financial-results-and-provides-business] (ACHV [https://seekingalpha.com...
Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting
Key Points Interested in Achieve Life Sciences, Inc.? Here are five stocks we like better. Achieve Life Sciences held its 2026 annual meeting and presented a slate of nine directors for election, inc...
Get Achieve Life Sciences Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.